Monday, February 20, 2017
Most Accessed Article: Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions
Related Posts:
Open Access Article : "HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of action, Clinical Activity, and Safety Profiles"
Most Accessed Article Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
Most Accessed Article:Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin
New Issue Published Current Cancer Drug Targets Vol 17 issue 6
Call For Paper
0 comments:
Post a Comment